Geneva Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
|
|||||
|
2025
Q1 | $1.93M | Buy |
|
|||||
|
2024
Q4 | $2.36M | Sell |
|
|||||
|
2024
Q3 | $2.92M | Sell |
|
|||||
|
2024
Q2 | $3.15M | Sell |
|
|||||
|
2024
Q1 | $4.48M | Buy |
|
|||||
|
2023
Q4 | $3.85M | Sell |
|
|||||
|
2023
Q3 | $3.48M | Sell |
|
|||||
|
2023
Q2 | $3.87M | Sell |
|
|||||
|
2023
Q1 | $3.92M | Sell |
|
|||||
|
2022
Q4 | $4.37M | Buy |
|
|||||
|
2022
Q3 | $3.93M | Sell |
|
|||||
|
2022
Q2 | $4.75M | Sell |
|
|||||
|
2022
Q1 | $6.38M | Buy |
|